United States· US:68788-7880_da87ba1c-5887-4492-8ae9-40a027d5e449
Armodafinil
A armodafinil product containing armodafinil, registered in United States by Preferred Pharmaceuticals Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ARMODAFINIL
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- N06BA13
- ATC class
- Armodafinil
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc11687887880330 TABLET in 1 BOTTLE (68788-7880-3)
- ndc11687887880660 TABLET in 1 BOTTLE (68788-7880-6)
- ndc11687887880990 TABLET in 1 BOTTLE (68788-7880-9)
- ndc1168788-7880-3
- ndc1168788-7880-6
- ndc1168788-7880-9
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
254 interactions on record for armodafinil.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Armodafinil · interactions on record
254 records
- 5 severe
- 144 moderate
- 105 minor
Most severe, free to view
- OlaparibL01XK01severe
- OlaparibL01XX46severe
- CocaineN01BC01severe
- CocaineR02AD03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N06BA13
Armodafinil, as other registers publish it.
- United StatesArmodafinilBryant Ranch Prepack
- United StatesArmodafinilSandoz Inc
- United StatesArmodafinilQuality Care Products LLC
- United StatesArmodafinilTeva Pharmaceuticals USA, Inc.
- United StatesArmodafinilNatco Pharma USA LLC
- United StatesArmodafinilNatco Pharma USA LLC
- United StatesArmodafinilSandoz Inc
- United StatesArmodafinilTeva Pharmaceuticals USA, Inc.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/272bb2bd-effd-4dd9-bdb4-aaba42cd0629 GET /v1/drugs/272bb2bd-effd-4dd9-bdb4-aaba42cd0629?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "150",
"substance": "ARMODAFINIL",
"productndc": "68788-7880",
"dosage_form": "TABLET",
"dea_schedule": "CIV",
"strength_unit": "mg/1",
"application_number": "ANDA206069",
"marketing_category": "ANDA"
}See everything about armodafinil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.